Search Press releases Keywords From To 6 Nov 2017 Dermira and UCB Agree to End Collaboration Agreement for CIMZIA Read More 5 Nov 2017 UCB’s VIMPAT® (lacosamide) now approved by FDA to treat partial-onset seizures in pediatric epilepsy patients Read More 20 Oct 2017 UCB First Nine Months Interim Report 2017: Strong 9 months performance allows for increase of 2017 financial outlook Read More 19 Oct 2017 By the time you finish reading this headline another person will have suffered a fragility fracture due to osteoporosis1 Read More 13 Oct 2017 Transparency notification The Capital Group Companies Read More 21 Sep 2017 UCB’s anti-epileptic drug VIMPAT® (lacosamide) receives EU approval for paediatric use Read More Pagination First page Previous page Previous … Page 74 Page 75 Page 76 Page 77 Current page 78 Page 79 Page 80 Page 81 Page 82 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
